CHGCF - Chugai Pharmaceutical Co. Ltd. (CHGCF) CEO Osamu Okuda on Q1 2021 Results - Earnings Call Transcript

Chugai Pharmaceutical Co., Ltd. (CHGCF) Q1 2021 Earnings Conference Call April 22, 2021 05:00 AM ET Company Participants Osamu Okuda - President & Chief Executive Officer Toshiaki Itagaki - Executive Vice President & Chief Financial Officer Tetsuya Yamaguchi - Senior Vice President, Head of Project & Lifecycle Management Unit Shinji Hidaka - Vice President and Head of Marketing & Sales Division Conference Call Participants Seiji Wakao - JPMorgan Shinichiro Muraoka - Morgan Stanley Fumiyoshi Sakai - Credit Suisse Securities Hidemaru Yamaguchi - Citi Securities Akinori Ueda - Goldman Sachs Motoya Kohtani - Nomura Securities Presentation Osamu Okuda Welcome to our conference call. I am Osamu Okuda, President and CEO of Chugai Pharmaceutical. I'd like to give you the overview of the First Quarter of Fiscal 2021. Please turn to page 5. Revenues in January to March quarter totaled ¥168.8 billion, down 5.9% year-on-year, while the operating income was ¥65.4 billion,

For further details see:

Chugai Pharmaceutical Co., Ltd. (CHGCF) CEO Osamu Okuda on Q1 2021 Results - Earnings Call Transcript